Current data has a 15-minute delay. Please / to get real-time quotes.
icon

Annexon

ANNX

ANNX Annexon NASDAQ
Add to watchlist
15.06
0.00 (0.00 %)
At close : Jan 03, 16:00 ET
--
  • Post market
  • 20:00 ET
    Summary
    Options
    Financials
    News
    Filings
    Profile
    ANNX Chart
    See on advanced chart >
    • Volume --
    • Turnover --
    • P/E(TTM) --
    • Turnover % --
    • P/E(Static) --
    • Market Cap --
    • P/B --
    • Shares --
    • 52 Week Range
    • Day Range

    About

    Annexon, Inc. was incorporated under the laws of the State of Delaware on March 3, 2011. The company is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body,...
    • Highlight
      A clinical-stage biopharmaceutical company that develops medicines for classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders
    • Industry
    • Exchange
      NASDAQ
    • Listing Date
      07/24/2020
    • Established Date
      03/03/2011
    • Full-time Employees
      71
    • Address
      1400 Sierra Point Parkway Bldg C Suite 200 Brisbane California 94005
    • Tel
      1-650-8225500
    • Website
    • Fiscal Year End Date
      12/31
    • Security Type
      Common Stock

    Option Block Monitor

    You Can Understand Stocks with AI.
    Why NVDA surged 16.40%?
    Because it
    fork
    logo
    AInvest
    Aime Coplilot
    Invest Smarter With AI Power.
    Open App